BioNexus secures Seed funding to enhance its AI scientist agent platform with the support of Bass Ventures and SMB Investment Partners.
Round Type
Seed
Investors
Description
AI-powered biotech R&D startup BioNexus announced on August 7 that it has secured Seed funding from Bass Ventures and SMB Investment Partners. The company plans to use the investment to enhance the core technology of its AI scientist agent platform, strengthen R&D capabilities, and accelerate business expansion. BioNexus develops an AI-based bio-data intelligence and scientist agent drug-discovery platform with a suite of innovative research tools. Since its founding, it has completed over 30 research projects and built a collaborative network with 15 institutions.
Quick answer
BioNexus raised an undisclosed amount in a Seed round, dated August 7, 2026. Investors: SMB Investment Partners and Bass Ventures.
- How much did BioNexus raise?
- BioNexus raised an undisclosed amount in a Seed round on August 7, 2026.
- Who invested in BioNexus?
- SMB Investment Partners and Bass Ventures are named as investors in this round.
- What does BioNexus do?
- BioNexus is an AI-powered biotech R&D startup that develops an AI-based bio-data intelligence and scientist agent drug-discovery platform.
- Where is BioNexus based and how big is it?
- Fundz records about 11 employees.
Source: Fundz verified event record.
Who else raised in Biotechnology and Artificial Intelligence around the same time
Companies in the same sectors as BioNexus that raised within 45 days of this round, from Fundz verified event records.
- Dental Robotics raised an undisclosed amount (Seed) on September 21, 2026.
- UCANACT raised $913K (Pre-Seed) on September 20, 2026.
- Polyphron raised $20M (Seed) on September 17, 2026.
- Anew Labs raised $290M on September 16, 2026.
- Apex Intelligence raised an undisclosed amount on September 16, 2026.
- Medow Health raised $2.6M (Seed) on September 16, 2026.
Who to call at BioNexus, and when
A new round usually means BioNexus is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day BioNexus raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at BioNexus, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at BioNexus. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment BioNexus raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
BioNexus raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.